By Canadian Press

Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer

Aug 18, 2023 | 10:29 AM

A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, the manufacturer says. 

Novo Nordisk says it is experiencing a temporary supply disruption with the Ozempic 1 mg injection pen. 

It says the shortage is due to a combination of global supply constraints and increased demand for the drug.

Health Canada says intermittent shortages are expected from late August to early October.

Both Health Canada and Novo Nordisk say the 0.25 mg and 0.5 mg doses of Ozempic remain available for patients with Type 2 diabetes.  

Battle of the Battlefords

NBCHS junior A girls win it all in home volleyball tournament

11h ago

Battlefords North Stars

Getting ready for Nipawin and new signing from BCHL

14h ago

Sask Energy

Natural Gas flaring being done in Meota

17h ago

They say pharmacists are encouraged to limit refill prescriptions to a 30-day supply.  

This report by The Canadian Press was first published Aug. 18, 2023.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content

Nicole Ireland, The Canadian Press